Cellcolabs’ $12M Funding Signals Stem Cell Commercialization Push
Cellcolabs secures $12 million to expand industrial stem cell production globally. The Swedish startup, backed by longevity guru Bryan Johnson, aims to make mesenchymal stem cells accessible for research and therapeutic applications worldwide.